{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:06:43Z","timestamp":1791176803131,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["NA7313"],"award-info":[{"award-number":["NA7313"]}],"id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008093","name":"Schulich School of Medicine and Dentistry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.cjca.2012.04.014","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T01:49:27Z","timestamp":1340070567000},"page":"706-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque"],"prefix":"10.1016","volume":"28","author":[{"given":"Omar","family":"de Rita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Hackam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2012.04.014_bib1","first-page":"318","article-title":"Resistant hypertension and aldosterone: an update","volume":"28","author":"Clark","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.04.014_bib2","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1161\/01.CIR.0000093188.53554.44","article-title":"Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation","volume":"108","author":"Liu","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.04.014_bib3","doi-asserted-by":"crossref","first-page":"C788","DOI":"10.1152\/ajpcell.00407.2006","article-title":"Rapid effects of aldosterone on clonal human vascular smooth muscle cells","volume":"292","author":"Gros","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"suppl A","key":"10.1016\/j.cjca.2012.04.014_bib4","first-page":"22A","article-title":"Rapid vascular effects of steroids - a question of balance?","volume":"26","author":"Feldman","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.04.014_bib5","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.04.014_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.04.014_bib7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.04.014_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/y05-068","article-title":"Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy","volume":"83","author":"Neves","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.cjca.2012.04.014_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/ATVBAHA.108.168021","article-title":"Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways","volume":"28","author":"Montezano","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2012.04.014_bib10","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1097\/HJH.0b013e328330a963","article-title":"Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction","volume":"27","author":"Leibovitz","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.04.014_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice","volume":"41","author":"Keidar","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cjca.2012.04.014_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/01.HYP.0000184652.93583.77","article-title":"Eplerenone antagonizes atherosclerosis, but what is the agonist?","volume":"46","author":"Strawn","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.04.014_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.0000184640.81730.22","article-title":"Eplerenone inhibits atherosclerosis in nonhuman primates","volume":"46","author":"Takai","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.04.014_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2012.04.014_bib15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/HYPERTENSIONAHA.107.104299","article-title":"Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability","volume":"51","author":"Imanishi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.04.014_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/HYPERTENSIONAHA.107.103267","article-title":"Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients","volume":"51","author":"Savoia","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2012.04.014_bib17","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","author":"Stowasser","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2012.04.014_bib18","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.STR.0000042207.16156.B9","article-title":"Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy","volume":"33","author":"Spence","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2012.04.014_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2011.06.044","article-title":"Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis","volume":"220","author":"Inaba","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2012.04.014_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.atherosclerosis.2011.07.006","article-title":"Carotid plaque measurement is superior to IMT","volume":"220","author":"Spence","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2012.04.014_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1161\/ATVBAHA.108.169292","article-title":"Lipoprotein(a) is associated differentially with carotid stenosis, occlusion, and total plaque area","volume":"28","author":"Klein","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2012.04.014_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.STR.30.5.969","article-title":"Plasma homocyst(e)ine, but not MTHFR genotype, is associated with variation in carotid plaque area","volume":"30","author":"Spence","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2012.04.014_bib23","first-page":"198","article-title":"Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area","volume":"48","author":"Hegele","year":"2000","journal-title":"J Invest Med"},{"key":"10.1016\/j.cjca.2012.04.014_bib24","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.STR.0000069160.05292.41","article-title":"Lipoprotein lipase (LPL) gene variation and progression of carotid artery plaque","volume":"34","author":"Spence","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2012.04.014_bib25","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.STR.0000190833.43791.be","article-title":"Disparate associations of a functional promoter polymorphism in PCK1 with carotid wall ultrasound traits","volume":"36","author":"Hegele","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2012.04.014_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCGENETICS.109.934505","article-title":"Extremes of unexplained variation as a phenotype: an efficient approach for genome-wide association studies of cardiovascular disease","volume":"3","author":"Lanktree","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.cjca.2012.04.014_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1470320309358109","article-title":"Preliminary studies on human aldosterone synthase (CYP11B2) gene polymorphism, matrix metalloprotease-9, apoptosis, and carotid atherosclerosis plaque size by proton magnetic resonance imaging","volume":"11","author":"Sharma","year":"2010","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.cjca.2012.04.014_bib28","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension","volume":"25","author":"Holaj","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.04.014_bib29","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/HJH.0b013e3282fd6932","article-title":"Increased carotid intima-media thickness in hypertensive patients with a high aldosterone\/plasma renin activity ratio and elevated aldosterone plasma concentration","volume":"26","author":"Gonzalez-Perez","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.04.014_bib30","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.STR.0000227223.90239.13","article-title":"Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials","volume":"37","author":"Wang","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2012.04.014_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/ATVBAHA.108.173609","article-title":"Correlation between carotid intimal\/medial thickness and atherosclerosis","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2012.04.014_bib32","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1161\/01.ATV.0000146160.22637.33","article-title":"Noninvasive phenotypes of atherosclerosis","volume":"24","author":"Spence","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2012.04.014_bib33","first-page":"61C","article-title":"The importance of distinguishing between diffuse carotid intima medial thickening and focal plaque","volume":"24","author":"Spence","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.04.014_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1753944707085982","article-title":"Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade","volume":"1","author":"Stumpe","year":"2007","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2012.04.014_bib35","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/STROKEAHA.110.577973","article-title":"Treating arteries instead of risk factors","volume":"41","author":"Spence","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2012.04.014_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004872-199715010-00004","article-title":"Psychological stress and the progression of carotid artery disease","volume":"15","author":"Barnett","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.cjca.2012.04.014_bib37","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cjca.2012.04.014_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0021-9150(99)00003-9","article-title":"An approach to ascertain probands with a non traditional risk factor for carotid atherosclerosis","volume":"144","author":"Spence","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2012.04.014_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ncpneuro0324","article-title":"Technology insight: ultrasound measurement of carotid plaque\u2013patient management, genetic research, and therapy evaluation","volume":"2","author":"Spence","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.cjca.2012.04.014_bib40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cjca.2012.04.014_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.mce.2011.09.008","article-title":"Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis","volume":"350","author":"Young","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cjca.2012.04.014_bib42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pharmthera.2005.10.010","article-title":"Rapid actions of aldosterone in vascular health and disease\u2013friend or foe?","volume":"111","author":"Skott","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2012.04.014_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.12.010","article-title":"RALES, EPHESUS and redox","volume":"93","author":"Funder","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.cjca.2012.04.014_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11906-010-0126-2","article-title":"Mineralocorticoid receptor antagonists and the metabolic syndrome","volume":"12","author":"Tirosh","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.cjca.2012.04.014_bib45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0002-9343(76)90161-3","article-title":"Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol","volume":"61","author":"Laragh","year":"1976","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2012.04.014_bib46","first-page":"254","article-title":"Lessons from Africa: the importance of measuring plasma renin and aldosterone in resistant hypertension","volume":"28","author":"Spence","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.04.014_bib47","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.04.014_bib48","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/01.STR.0000178543.19433.20","article-title":"3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies","volume":"36","author":"Ainsworth","year":"2005","journal-title":"Stroke"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12002000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12002000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:36:18Z","timestamp":1760106978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X12002000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0828282X12002000"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2012.04.014","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Aldosterone on Human Atherosclerosis: Plasma Aldosterone and Progression of Carotid Plaque","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2012.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}